The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPod Point Regulatory News (PODP)

Share Price Information for Pod Point (PODP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.75
Bid: 22.50
Ask: 22.95
Change: 0.75 (3.41%)
Spread: 0.45 (2.00%)
Open: 22.75
High: 22.75
Low: 22.75
Prev. Close: 22.00
PODP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

21 Nov 2022 07:00

RNS Number : 9867G
Pod Point Group Holdings PLC
21 November 2022
 

21 November 2022

 

Pod Point Group Holdings plc

(the "Group")

 

Trading update

The long-term market for Plug-In-vehicles (PIVs) continues to be attractive as the industry grows towards electrification in the UK by 2030.

However, growth in the second half of 2022 has slowed markedly, which has been driven by supply chain challenges in car manufacturing causing reduced deliveries into the UK. Automotive companies continue to report long lead times for customers wishing to place orders.

SMMT data demonstrates that the growth rate of PIVs from 2020 to 2021 was 76% year on year. The growth of PIVs in the first half of 2022 of 26% has since slowed to 7% in the four months to 31st October 2022. These continued trends indicate the total market for PIVs will be circa 350,000 in 2022 and circa 375,000 in 2023.

As noted in the interim results, our first half 2022 market share in the Home segment (calculated as number of Home installs divided by new PIV registrations) benefitted from customers scheduling their installs in advance of vehicle delivery ahead of the cessation of the Government funded OZEV home grant on 31 March 2022. This scheduling change remains a factor in the current market, and allowing for this, we expect full year market share in the Home segment to stabilise around our long term historical share.

As a result of these challenges the Group expects full year 2022 revenues to be approximately £70m with an adjusted EBITDA loss of circa £7m.

The Group continues to benefit from a strong balance sheet with year-end cash expected to be in excess of £70 million in line with guidance provided at H1.

2023 outlook

Whilst it is today difficult to predict the outcome for 2023, we are prudently assuming that these supply chain and macroeconomic issues extend into 2023, and thus the Group expects full year revenues for 2023 to be in the region of £85 to £90m.

This reduction in revenues will impact adjusted EBITDA, delivering a mid-single digital adjusted EBITDA loss in 2023.

The Group is expected to maintain a strong balance sheet and to end 2023 with around £50 million of cash, after required investment. We will continue to invest in hardware and software development to drive revenue growth, combined with further investment in Owned Assets at a targeted and limited level.

In the longer term, the Group expects the UK to return to rapid growth in PIV registrations as the supply chain restrictions and general economy recover. We fully expect the UK to achieve its goal of banning new internal combustion engine cars by 2030, and hence foresee strong growth in demand for charging infrastructure over the next decade and beyond.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Group's obligations under Article 17 of MAR.

 

ENDS

 

Enquiries: 

Tulchan (Public Relations adviser to Pod Point)

James Macey White/ Mark Burgess/ Matt Low/ Arthur Rogers

+44 (0)20 7353 4200 / PodPoint@tulchangroup.com

BofA Securities (Joint Corporate broker)

Peter Luck, Marcus Jackson, Mitchell Evans

+44 (0)20 7628 1000

Numis (Joint Corporate broker)

Andrew Coates

 

+44 (0)20 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZMZMMGVGZZZ
12
Date   Source Headline
30th Apr 202411:00 amRNSTotal Voting Rights
26th Apr 20242:29 pmRNSAnnual Report & Notice of AGM
19th Apr 202411:32 amRNSDirector/PDMR Shareholding
18th Apr 20247:00 amRNSPreliminary Results for FY2023
3rd Apr 20247:00 amRNSNotice of Results
3rd Apr 20247:00 amRNSChange of Joint Corporate Broker
2nd Apr 20249:00 amRNSEstablishment of Technology Committee
12th Mar 20249:00 amRNSChange of Registered Office
29th Feb 20248:33 amRNSTotal Voting Rights
20th Feb 20247:00 amRNSCEO Appointment & Directorate Change
20th Feb 20247:00 amRNSTrading Update
14th Feb 202411:24 amRNSBlock Listing Application
31st Jan 202410:45 amRNSTotal Voting Rights
10th Jan 202410:07 amRNSDirector Declaration
8th Dec 20238:47 amRNSBlock listing Interim Review
20th Nov 20233:13 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSTrading Update and Capital Markets Day
17th Aug 20232:29 pmRNSNotice of Capital Markets Day
10th Aug 20239:00 amRNSNew Contract Win
31st Jul 20237:00 amRNSHalf-year Report
28th Jul 20239:00 amRNSChange of Auditor
27th Jul 20234:11 pmRNSUpdated 2023 Guidance
6th Jul 20237:00 amRNSDirectorate Change
30th Jun 20239:00 amRNSNew Contract Win
28th Jun 20239:00 amRNSNew Contract Win
14th Jun 202310:10 amRNSResult of AGM
8th Jun 20239:14 amRNSBlock listing Interim Review
31st May 20239:29 amRNSDirector Declaration
25th May 20231:50 pmRNSDirector/PDMR Shareholding
28th Apr 20235:27 pmRNSAnnual Report & Notice of AGM
31st Mar 20233:47 pmRNSDirector/PDMR Shareholding
31st Mar 202310:24 amRNSTotal Voting Rights
21st Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20234:35 pmRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20231:37 pmRNSBlock Listing Application
17th Feb 20237:00 amRNSPreliminary Unaudited Results for FY2022
16th Feb 20239:58 amRNSBoard Committee Change
11th Jan 20237:00 amRNSCompany Secretary Change
3rd Jan 20237:00 amRNSTotal Voting Rights
28th Dec 202210:32 amRNSDirector/PDMR Shareholding
22nd Dec 20224:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 20227:00 amRNSExercise of Options and Issue of Shares
9th Dec 20227:00 amRNSBlock listing Interim Review
5th Dec 20227:00 amRNSCFO Appointment
21st Nov 20227:00 amRNSTrading Statement
7th Nov 20224:40 pmRNSSecond Price Monitoring Extn
7th Nov 20224:35 pmRNSPrice Monitoring Extension
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.